Coronary artery bypass grafting versus drug-eluting stent implantation for left main coronary artery disease (from a two-center registry).
Drug-coated balloon angioplasty with rescue stenting versus intended stenting for the treatment of patients with de novo coronary artery lesions (REC-CAGEFREE I): an open-label, randomised, non-inferiority trial.
Gao C, He X, Ouyang F, Zhang Z, Shen G, Wu M, Yang P, Ma L, Yang F, Ji Z, Wang H, Wu Y, Fang Z, Jiang H, Wen S, Liu Y, Li F, Zhou J, Zhu B, Liu Y, Zhang R, Zhang T, Wang P, Liu J, Jiang Z, Xia J, van Geuns RJ, Capodanno D, Garg S, Onuma Y, Wang D, Serruys PW, Tao L; REC-CAGEFREE I Investigators.
Lancet. 2024 Sep 14;404(10457):1040-1050. doi: 10.1016/S0140-6736(24)01594-0. Epub 2024 Sep 2.
Long-term outcomes of IVUS-guided and angiography-guided drug-eluting stent implantation for left main coronary artery disease: a retrospective consort study.
Yang Q, Ma X, Wang Y.
J Cardiothorac Surg. 2024 Jul 1;19(1):407. doi: 10.1186/s13019-024-02800-0.
Optical coherence tomography-guided versus angiography-guided percutaneous coronary intervention for patients with complex lesions (OCCUPI): an investigator-initiated, multicentre, randomised, open-label, superiority trial in South Korea.
Hong SJ, Lee SJ, Lee SH, Lee JY, Cho DK, Kim JW, Kim SM, Hur SH, Heo JH, Jang JY, Koh JS, Won H, Lee JW, Hong SJ, Kim DK, Choe JC, Lee JB, Kim SJ, Yang TH, Lee JH, Hong YJ, Ahn JH, Lee YJ, Ahn CM, Kim JS, Ko YG, Choi D, Hong MK, Jang Y, Kim BK; OCCUPI investigators.
Lancet. 2024 Sep 14;404(10457):1029-1039. doi: 10.1016/S0140-6736(24)01454-5. Epub 2024 Sep 2.
[Prognostic analysis of drug-eluting stent implantation and coronary artery bypass grafting in patients with unprotected left main coronary artery disease complicated with chronic renal failure].
Pan Y, Mu Y, Zhang Y, He J, Qiu Q.
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020 Oct;32(10):1203-1207. doi: 10.3760/cma.j.cn121430-20200518-00391.
Two-year outcomes of bioresorbable vascular scaffold versus drug-eluting stents in coronary artery disease: a meta-analysis.
Nairooz R, Saad M, Sardar P, Aronow WS.
Heart. 2017 Jul;103(14):1096-1103. doi: 10.1136/heartjnl-2016-310886. Epub 2017 Jan 23.
Drug-Eluting or Bare-Metal Stents for Coronary Artery Disease.
Bønaa KH, Mannsverk J, Wiseth R, Aaberge L, Myreng Y, Nygård O, Nilsen DW, Kløw NE, Uchto M, Trovik T, Bendz B, Stavnes S, Bjørnerheim R, Larsen AI, Slette M, Steigen T, Jakobsen OJ, Bleie Ø, Fossum E, Hanssen TA, Dahl-Eriksen Ø, Njølstad I, Rasmussen K, Wilsgaard T, Nordrehaug JE; NORSTENT Investigators.
N Engl J Med. 2016 Sep 29;375(13):1242-52. doi: 10.1056/NEJMoa1607991. Epub 2016 Aug 29.
Coronary artery bypass grafting vs. drug-eluting stent implantation in patients with end-stage renal disease requiring dialysis.
Wang Z, Gong Y, Fan F, Yang F, Qiu L, Hong T, Huo Y.
Ren Fail. 2020 Nov;42(1):107-112. doi: 10.1080/0886022X.2019.1710187.
Comparison of noninvasive follow-up testing in patients after percutaneous coronary intervention with drug-eluting stent implantation.
Seki T, Takeuchi M, Kawakami K.
J Cardiol. 2022 Sep;80(3):275-282. doi: 10.1016/j.jjcc.2022.05.001. Epub 2022 May 21.
[Long-term prognosis of drug eluting stents implantation in elderly patients with unprotected left main coronary artery disease].
Pan Y, Qiu Q, Mu Y, Wu Z, Yu XP, He JQ.
Zhonghua Yi Xue Za Zhi. 2020 Jun 9;100(22):1720-1724. doi: 10.3760/cma.j.cn112137-20191030-02355.
Effect of lipoprotein(a) levels on long-term outcome in octogenarians with coronary artery disease after drug-eluting stent implantation.
Hu B, Zhou Y, Shi D, Zhao Y, Jia D, Yang S, Jia S, Xu X, Ma X.
Rev Cardiovasc Med. 2022 Mar 1;23(3):79. doi: 10.31083/j.rcm2303079.
